Haleon plc (LON:HLN) Insider Asmita Dubey Buys 15,424 Shares of Stock

Haleon plc (LON:HLNGet Free Report) insider Asmita Dubey acquired 15,424 shares of the company’s stock in a transaction on Friday, May 2nd. The stock was acquired at an average price of GBX 401 ($5.32) per share, with a total value of £61,850.24 ($82,051.26).

Haleon Price Performance

Shares of LON HLN opened at GBX 398.40 ($5.29) on Friday. Haleon plc has a 1 year low of GBX 319.84 ($4.24) and a 1 year high of GBX 417.70 ($5.54). The stock has a market capitalization of £35.96 billion, a P/E ratio of 33.51, a P/E/G ratio of 1.49 and a beta of 0.19. The company’s 50-day moving average is GBX 385.59 and its 200 day moving average is GBX 379.73. The company has a debt-to-equity ratio of 53.36, a current ratio of 0.84 and a quick ratio of 0.93.

Haleon (LON:HLNGet Free Report) last announced its earnings results on Friday, February 28th. The company reported GBX 15.80 ($0.21) earnings per share (EPS) for the quarter. Haleon had a return on equity of 6.54% and a net margin of 9.66%. On average, sell-side analysts expect that Haleon plc will post 19.5033282 earnings per share for the current year.

Haleon Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Thursday, April 24th will be issued a dividend of GBX 4.60 ($0.06) per share. This represents a dividend yield of 1.18%. The ex-dividend date is Thursday, April 24th. This is a boost from Haleon’s previous dividend of $2.00. Haleon’s payout ratio is 50.46%.

Analyst Ratings Changes

Separately, Berenberg Bank raised their price target on Haleon from GBX 456 ($6.05) to GBX 457 ($6.06) and gave the stock a “buy” rating in a research note on Friday, February 28th.

Check Out Our Latest Research Report on HLN

About Haleon

(Get Free Report)

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.

See Also

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.